DE69735481D1 - Verwendung eines magnetischen materials zur Herstellung eines Medikaments für gezielte Hysterese Hyperthermie - Google Patents

Verwendung eines magnetischen materials zur Herstellung eines Medikaments für gezielte Hysterese Hyperthermie

Info

Publication number
DE69735481D1
DE69735481D1 DE69735481T DE69735481T DE69735481D1 DE 69735481 D1 DE69735481 D1 DE 69735481D1 DE 69735481 T DE69735481 T DE 69735481T DE 69735481 T DE69735481 T DE 69735481T DE 69735481 D1 DE69735481 D1 DE 69735481D1
Authority
DE
Germany
Prior art keywords
magnetic material
pct
patient
diseased tissue
medicament
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Revoked
Application number
DE69735481T
Other languages
English (en)
Other versions
DE69735481T2 (de
Inventor
Nathaniel Gray
Keith Jones
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sirtex Medical Pty Ltd
Original Assignee
Sirtex Medical Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=3794095&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69735481(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sirtex Medical Pty Ltd filed Critical Sirtex Medical Pty Ltd
Publication of DE69735481D1 publication Critical patent/DE69735481D1/de
Application granted granted Critical
Publication of DE69735481T2 publication Critical patent/DE69735481T2/de
Anticipated expiration legal-status Critical
Revoked legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N2/00—Magnetotherapy
    • A61N2/02—Magnetotherapy using magnetic fields produced by coils, including single turn loops or electromagnets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5094—Microcapsules containing magnetic carrier material, e.g. ferrite for drug targeting
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0052—Thermotherapy; Hyperthermia; Magnetic induction; Induction heating therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/40—Applying electric fields by inductive or capacitive coupling ; Applying radio-frequency signals
    • A61N1/403—Applying electric fields by inductive or capacitive coupling ; Applying radio-frequency signals for thermotherapy, e.g. hyperthermia
    • A61N1/406—Applying electric fields by inductive or capacitive coupling ; Applying radio-frequency signals for thermotherapy, e.g. hyperthermia using implantable thermoseeds or injected particles for localized hyperthermia
DE69735481T 1996-05-10 1997-05-09 Verwendung eines magnetischen Materials zur Herstellung eines Medikaments für gezielte Hysterese Hyperthermie Revoked DE69735481T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AUPN978296 1996-05-10
AUPN9782A AUPN978296A0 (en) 1996-05-10 1996-05-10 Targeted hysteresis hyperthermia as a method for treating cancer
PCT/AU1997/000287 WO1997043005A1 (en) 1996-05-10 1997-05-09 Targeted hysteresis hyperthermia as a method for treating diseased tissue

Publications (2)

Publication Number Publication Date
DE69735481D1 true DE69735481D1 (de) 2006-05-11
DE69735481T2 DE69735481T2 (de) 2006-10-12

Family

ID=3794095

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69735481T Revoked DE69735481T2 (de) 1996-05-10 1997-05-09 Verwendung eines magnetischen Materials zur Herstellung eines Medikaments für gezielte Hysterese Hyperthermie

Country Status (11)

Country Link
US (2) US6167313A (de)
EP (1) EP0952873B1 (de)
JP (1) JP2000503879A (de)
KR (1) KR20000034772A (de)
CN (1) CN1218415A (de)
AT (1) ATE320283T1 (de)
AU (1) AUPN978296A0 (de)
CA (1) CA2253963A1 (de)
DE (1) DE69735481T2 (de)
ES (1) ES2260789T3 (de)
WO (1) WO1997043005A1 (de)

Families Citing this family (87)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPN978296A0 (en) 1996-05-10 1996-05-30 Gray, Bruce N Targeted hysteresis hyperthermia as a method for treating cancer
US6423056B1 (en) * 1998-12-31 2002-07-23 Ball Semiconductor, Inc. Injectable thermal balls for tumor ablation
AUPP899899A0 (en) * 1999-03-03 1999-03-25 Paragon Medical Limited Magnetic material
US6470220B1 (en) * 1999-03-29 2002-10-22 The Regents Of The University Of California Diagnosis and treatment of cancers using in vivo magnetic domains
DE19937493C2 (de) 1999-08-07 2001-06-07 Mfh Hyperthermiesysteme Gmbh Magnetfeldapplikator zur Aufheizung von magnetischen oder magnetisierbaren Substanzen oder Festkörpern in biologischem Gewebe
DE19937492C2 (de) 1999-08-07 2001-08-23 Mfh Hyperthermiesysteme Gmbh Magnetfeldapplikator zur Aufheizung von magnetischen oder magnetisierbaren Substanzen oder Festkörpern in biologischem Gewebe
US6530944B2 (en) * 2000-02-08 2003-03-11 Rice University Optically-active nanoparticles for use in therapeutic and diagnostic methods
US6794376B2 (en) * 2000-12-06 2004-09-21 William Beaumont Hospital Methods and compositions for enhancing diffusion of therapeutic agents through tissue
DE10109105C2 (de) * 2001-02-24 2003-01-09 Mfh Hyperthermiesysteme Gmbh Magnetspulenanordnung eines Magnetfeldapplikators zur Aufheizung von magnetischen oder magnetisierbaren Substanzen oder Festkörpern in biologischem Gewebe
US20050080468A1 (en) * 2001-03-26 2005-04-14 Lawrence C. Christman Methods and apparatus for treating diseased tissue
US7951061B2 (en) 2001-07-25 2011-05-31 Allan Foreman Devices for targeted delivery of thermotherapy, and methods related thereto
US7074175B2 (en) 2001-07-25 2006-07-11 Erik Schroeder Handy Thermotherapy via targeted delivery of nanoscale magnetic particles
US7731648B2 (en) * 2001-07-25 2010-06-08 Aduro Biotech Magnetic nanoscale particle compositions, and therapeutic methods related thereto
US6997863B2 (en) 2001-07-25 2006-02-14 Triton Biosystems, Inc. Thermotherapy via targeted delivery of nanoscale magnetic particles
US7048756B2 (en) * 2002-01-18 2006-05-23 Apasara Medical Corporation System, method and apparatus for evaluating tissue temperature
US6993394B2 (en) * 2002-01-18 2006-01-31 Calfacion Corporation System method and apparatus for localized heating of tissue
US6850804B2 (en) * 2002-01-18 2005-02-01 Calfacior Corporation System method and apparatus for localized heating of tissue
EP1487460A2 (de) 2002-02-28 2004-12-22 A & D Bioscience, Inc. Glycuronamide, glycoside und orthoester-glycoside von fluoxetin, analoga und ihre verwendungen
WO2003079980A2 (en) * 2002-03-19 2003-10-02 A & D Bioscience, Inc. Caboxylic acid glycuronides, glycosamides and glycosides of quinolones, penicillins, analogs, and uses thereof
US20050255038A1 (en) * 2002-04-12 2005-11-17 A And D Bioscience, Inc. Conjugates comprising cancer cell specific ligands, a sugar and diagnostic agents and uses thereof
US6962685B2 (en) 2002-04-17 2005-11-08 International Business Machines Corporation Synthesis of magnetite nanoparticles and the process of forming Fe-based nanomaterials
US20050153928A1 (en) * 2002-05-07 2005-07-14 Holick Michael F. Conjugates comprising a central nervous system-active drug linked to glucuronic acid or glucosamine through an amide bond and uses thereof
US7670623B2 (en) 2002-05-31 2010-03-02 Materials Modification, Inc. Hemostatic composition
US20040002663A1 (en) * 2002-06-26 2004-01-01 Reeves William H. Method and system for use in detecting a cancerous and precancerous pathology
US20050215487A1 (en) * 2002-06-27 2005-09-29 Holick Michael F Conjugates comprising an nsaid and a sugar and uses thereof
DE10238853A1 (de) * 2002-08-24 2004-03-04 Philips Intellectual Property & Standards Gmbh Verfahren zur lokalen Erwärmung mit magnetischen Partikeln
US8012454B2 (en) 2002-08-30 2011-09-06 Boston Scientific Scimed, Inc. Embolization
US6895282B2 (en) * 2002-10-04 2005-05-17 Boston Scientific Scimed, Inc. Induction heating for the delivery of thermal therapy
AU2003900335A0 (en) * 2003-01-22 2003-02-13 Sirtex Medical Limited Microparticles for selectively targeted hyperthermia
US20040156846A1 (en) * 2003-02-06 2004-08-12 Triton Biosystems, Inc. Therapy via targeted delivery of nanoscale particles using L6 antibodies
US7007972B1 (en) 2003-03-10 2006-03-07 Materials Modification, Inc. Method and airbag inflation apparatus employing magnetic fluid
WO2004091393A1 (en) * 2003-04-15 2004-10-28 Philips Intellectual Property & Standards Gmbh Arrangement for influencing magnetic particles
EP1615694B1 (de) * 2003-04-15 2017-06-14 Philips Intellectual Property & Standards GmbH Verfahren und anordnung zur beeinflussung magnetischer partikel
US8012150B2 (en) 2003-05-01 2011-09-06 Covidien Ag Method and system for programming and controlling an electrosurgical generator system
US20070003975A1 (en) * 2003-05-02 2007-01-04 Canon Kabushiki Kaisha Structured construct and producing method therefor
JP2004331750A (ja) * 2003-05-02 2004-11-25 Canon Inc ポリヒドロキシアルカノエートを含有する磁性構造体及びその製造方法ならびにその用途
US6982501B1 (en) 2003-05-19 2006-01-03 Materials Modification, Inc. Magnetic fluid power generator device and method for generating power
DE20321545U1 (de) * 2003-06-12 2007-11-29 Man Roland Druckmaschinen Ag Schneidzylinder zum Querschneiden einer Bedruckstoffbahn in einer Rotationsdruckmaschine
US20040258614A1 (en) * 2003-06-20 2004-12-23 University Of Maryland, Baltimore Microparticles for microarterial imaging and radiotherapy
FR2857268B1 (fr) * 2003-07-08 2007-09-21 Urodelia Composite injectable pour magnetocytolyse de cellules metastatiques osseuses
US7200956B1 (en) 2003-07-23 2007-04-10 Materials Modification, Inc. Magnetic fluid cushioning device for a footwear or shoe
US7976823B2 (en) 2003-08-29 2011-07-12 Boston Scientific Scimed, Inc. Ferromagnetic particles and methods
US20050090732A1 (en) * 2003-10-28 2005-04-28 Triton Biosystems, Inc. Therapy via targeted delivery of nanoscale particles
US7627381B2 (en) * 2004-05-07 2009-12-01 Therm Med, Llc Systems and methods for combined RF-induced hyperthermia and radioimmunotherapy
US20050251233A1 (en) * 2004-05-07 2005-11-10 John Kanzius System and method for RF-induced hyperthermia
US7311861B2 (en) 2004-06-01 2007-12-25 Boston Scientific Scimed, Inc. Embolization
US20070135913A1 (en) * 2004-06-29 2007-06-14 Micardia Corporation Adjustable annuloplasty ring activation system
US7713298B2 (en) * 2004-06-29 2010-05-11 Micardia Corporation Methods for treating cardiac valves with adjustable implants
US20080183285A1 (en) * 2004-06-29 2008-07-31 Micardia Corporation Adjustable cardiac valve implant with selective dimensional adjustment
US20060015178A1 (en) * 2004-07-15 2006-01-19 Shahram Moaddeb Implants and methods for reshaping heart valves
ES2255831B1 (es) * 2004-08-06 2007-07-16 Daniel Serrano Gil Disposicion y metodo para destruccion selectiva de acumulaciones celulares de gran actividad con proliferacion celular incontrolada.
US20060047316A1 (en) * 2004-08-31 2006-03-02 Fischell Robert E System for the treatment of migraine headaches
WO2006051732A1 (ja) * 2004-11-10 2006-05-18 Konica Minolta Medical & Graphic, Inc. 被覆磁性粒子含有製剤およびその製造方法、並びに診断治療システム
US7858183B2 (en) 2005-03-02 2010-12-28 Boston Scientific Scimed, Inc. Particles
US7963287B2 (en) 2005-04-28 2011-06-21 Boston Scientific Scimed, Inc. Tissue-treatment methods
JP4911915B2 (ja) * 2005-05-09 2012-04-04 トヨタ自動車株式会社 標的物の分解方法及び分解装置
DE102005032372A1 (de) * 2005-07-08 2006-10-19 Siemens Ag Neurokapsel
US20090312637A1 (en) * 2005-08-03 2009-12-17 Koninklijke Philips Electronics, N.V. Ultrasound monitoring and feedback for magnetic hyperthermia
US20070055368A1 (en) * 2005-09-07 2007-03-08 Richard Rhee Slotted annuloplasty ring
US20070142907A1 (en) * 2005-12-16 2007-06-21 Micardia Corporation Adjustable prosthetic valve implant
DE102005060834A1 (de) 2005-12-20 2007-06-28 Grönemeyer Holding GmbH & Co. KG Magnetfeldapplikator
US7536228B2 (en) 2006-03-24 2009-05-19 Micardia Corporation Activation device for dynamic ring manipulation
EP2000150B1 (de) * 2006-03-24 2016-07-13 Toto Ltd. Titanoxidkomplexteilchen, dispersionslösung des teilchens und herstellungsverfahren für das teilchen
US7892520B2 (en) * 2006-07-31 2011-02-22 The Hong Kong University Of Science And Technology Solid-state synthesis of iron oxide nanoparticles
CN101553889A (zh) 2006-09-05 2009-10-07 哥伦布纳米制品公司 磁性颗粒及其制备方法和使用方法
WO2008060393A2 (en) * 2006-10-24 2008-05-22 Iso Therapeutics Group Llc The use of materials and external stimuli for synovectomy
WO2008053482A2 (en) * 2006-11-02 2008-05-08 Shlomo Laniado Application of magnetic field to treat tissue
US20080228272A1 (en) * 2006-12-04 2008-09-18 Micardia Corporation Dynamically adjustable suture and chordae tendinae
US20100106181A1 (en) * 2007-01-08 2010-04-29 Yossi Gross In-situ filter
US9493817B2 (en) * 2007-03-05 2016-11-15 Genesis Research Institute, Inc. Decomposition method and decomposition apparatus for nucleic acid polymer
US9861424B2 (en) 2007-07-11 2018-01-09 Covidien Lp Measurement and control systems and methods for electrosurgical procedures
ES2320837B1 (es) 2007-07-26 2010-03-04 Consejo Superior De Investigaciones Cientificas Dispositivo de hipertermia y su utilizacion con nanoparticulas.
US8152800B2 (en) 2007-07-30 2012-04-10 Vivant Medical, Inc. Electrosurgical systems and printed circuit boards for use therewith
US7645142B2 (en) 2007-09-05 2010-01-12 Vivant Medical, Inc. Electrical receptacle assembly
US8747398B2 (en) 2007-09-13 2014-06-10 Covidien Lp Frequency tuning in a microwave electrosurgical system
US20100018674A1 (en) * 2008-07-22 2010-01-28 Donald John Enzinna Reservoir with moveable partition for quick recovery
US10828100B2 (en) * 2009-08-25 2020-11-10 Covidien Lp Microwave ablation with tissue temperature monitoring
US8565892B2 (en) * 2009-10-31 2013-10-22 Qteris, Inc. Nanoparticle-sized magnetic absorption enhancers having three-dimensional geometries adapted for improved diagnostics and hyperthermic treatment
EA019412B1 (ru) * 2011-06-01 2014-03-31 Государственное Научное Учреждение "Институт Тепло- И Массообмена Имени А.В. Лыкова Национальной Академии Наук Беларуси" Способ локальной гипертермии злокачественных опухолей
US9005151B2 (en) 2011-09-07 2015-04-14 Choon Kee Lee Thermal apparatus
BRPI1104888B1 (pt) * 2011-09-29 2020-12-08 Instituto De Pesquisas Tecnológicas Do Est. S. Paulo S/a Ipt material magnético nanoparticulado para aplicações térmicas
KR101409296B1 (ko) * 2012-09-07 2014-06-24 서울대학교산학협력단 자성 나노 입자의 선택적 활성화 방법 및 선택적 활성화되는 자성 나노 입자
US10092769B2 (en) 2015-01-29 2018-10-09 Aerotel Ltd. Apparatus for non-invasive therapy of biological tissue using directed magnetic beams
WO2017188725A1 (ko) * 2016-04-29 2017-11-02 서울대학교산학협력단 온열 치료 장치
CN108525128B (zh) * 2018-03-26 2021-02-12 清华大学 液态金属作为肿瘤磁热疗介质的应用
KR102256971B1 (ko) * 2019-03-13 2021-05-26 재단법인대구경북과학기술원 체내에 위치한 관심 영역의 온도를 조절하는 마이크로로봇
KR102569850B1 (ko) * 2020-02-14 2023-08-24 서울대학교산학협력단 공명현상을 이용한 자성 나노 입자의 발열 방법

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4106488A (en) * 1974-08-20 1978-08-15 Robert Thomas Gordon Cancer treatment method
US4303636A (en) * 1974-08-20 1981-12-01 Gordon Robert T Cancer treatment
US4323056A (en) * 1980-05-19 1982-04-06 Corning Glass Works Radio frequency induced hyperthermia for tumor therapy
FR2508802A1 (fr) * 1981-07-03 1983-01-07 Thomson Csf Procede d'hyperthermie medicale utilisant une poudre magnetique par voie sanguine, et dispositif de mise en oeuvre de ce procede
US4574782A (en) * 1981-11-16 1986-03-11 Corning Glass Works Radio frequency-induced hyperthermia for tumor therapy
US4545368A (en) * 1983-04-13 1985-10-08 Rand Robert W Induction heating method for use in causing necrosis of neoplasm
US4662359A (en) * 1983-08-12 1987-05-05 Robert T. Gordon Use of magnetic susceptibility probes in the treatment of cancer
US4983159A (en) * 1985-03-25 1991-01-08 Rand Robert W Inductive heating process for use in causing necrosis of neoplasms at selective frequencies
JPH0288059A (ja) * 1988-09-26 1990-03-28 Univ Kyoto 温熱療法用セラミックス発熱体及びその製造方法
US5197940A (en) * 1990-01-29 1993-03-30 Hypertherm Corp. Local application tumor treatment apparatus
US5236410A (en) * 1990-08-02 1993-08-17 Ferrotherm International, Inc. Tumor treatment method
JPH06254168A (ja) * 1991-10-29 1994-09-13 Tanaka Kikinzoku Kogyo Kk 組織内加温温熱療法
US5411730A (en) * 1993-07-20 1995-05-02 Research Corporation Technologies, Inc. Magnetic microparticles
US5429583A (en) * 1993-12-09 1995-07-04 Pegasus Medical Technologies, Inc. Cobalt palladium seeds for thermal treatment of tumors
US5567746A (en) * 1994-12-16 1996-10-22 General Motors Corporation Moldable ferromagnetic particles and method
DE19600744A1 (de) 1996-01-11 1997-07-17 Werner Alois Prof Dipl Kaiser Magnetische Substanz zur lokalen hyperthermischen Behandlung vorwiegend kleiner Tumore
AUPN978296A0 (en) 1996-05-10 1996-05-30 Gray, Bruce N Targeted hysteresis hyperthermia as a method for treating cancer
AU2627797A (en) 1996-05-10 1997-12-05 Paragon Medical Limited Targeted hysteresis hyperthermia as a method for treating diseased tissue
AUPP008197A0 (en) 1997-10-29 1997-11-20 Paragon Medical Limited Improved targeted hysteresis hyperthermia as a method for treating diseased tissue

Also Published As

Publication number Publication date
ATE320283T1 (de) 2006-04-15
AUPN978296A0 (en) 1996-05-30
JP2000503879A (ja) 2000-04-04
CN1218415A (zh) 1999-06-02
EP0952873A1 (de) 1999-11-03
US6167313A (en) 2000-12-26
KR20000034772A (ko) 2000-06-26
EP0952873A4 (de) 2000-11-02
EP0952873B1 (de) 2006-03-15
CA2253963A1 (en) 1997-11-20
DE69735481T2 (de) 2006-10-12
ES2260789T3 (es) 2006-11-01
US6565887B1 (en) 2003-05-20
WO1997043005A1 (en) 1997-11-20

Similar Documents

Publication Publication Date Title
DE69735481D1 (de) Verwendung eines magnetischen materials zur Herstellung eines Medikaments für gezielte Hysterese Hyperthermie
DE69834790D1 (de) Hysteresehyperthermie zur Behandlung eines Gewebes
ATE103189T1 (de) Chirurgisches material und verwendung des materials zur herstellung (eines teiles) einer anordnung zur verwendung in der knochenchirurgie.
ATE164067T1 (de) Verwendung von riluzole zur behandlung von traumatischen neurologischen-schädigungen
DE69524944D1 (de) Methode zum herstellen eines dentalproduktes
DE69513167D1 (de) Perfluoroalkyll ketone, inhibitoren von elastase und prozess zur deren herstellung
DE69329559T2 (de) Verwendung von mannosephosphaten zur behandlung von fibrotischen störungen
DE69506703D1 (de) Beatmungsgerät
NO931809D0 (no) Hemofilter
ATE163913T1 (de) Ungesättigte aliphatische dicarbonsäuren
DE69508192T2 (de) Wasserlösliches nimesulid-salz, sowie dessen verwendung zur behandlung von entzündungen
ATE204174T1 (de) Verwendung von teilchen eines bioverträglichen und bioresorbierbaren kalziumsalzes als wirkstoff in der herstellung eines arzneimittels zur lokalen behandlung von entkalkungskrankheiten
DE69526937D1 (de) Verwendung von methanbisphosphonsäurederivaten zur behandlung von aufgelockerten prothesen
ATE307203T1 (de) Verwendung eines anti-interleukin-9 antikörpers zur herstellung eines medikamentes zur behandlung von asthma
DE59508454D1 (de) Polymermaterial von medizinischen instrumenten und verfahren zur herstellung des polymermaterials
BR0008968A (pt) Superfìcies hemocompatìveis e processo para aprodução das mesmas
DE69315085T2 (de) 1,4-disubstituierte piperazine zur behandlung von asthma und entzündungen der atemwege
NO20001799D0 (no) Fremgangsmåte for rensing av kirurgiske instrumenter
DE69026511D1 (de) Verwendung von gibberellinen zur herstellung eines arzneimittels zur behandlung von prostatitis
ATE200624T1 (de) Verwendung von 4'-iodo - 4 - deoxydoxorubicin zur behandlung von amyloidosis
ATE239458T1 (de) Verwendung von selegilin zur behandlung von epileptischen erkrankungen
ATE265444T1 (de) D-ring modifizierte gibberellinverbindungen und ihre herstellung und verwendung
DE59009724D1 (de) Verwendung von 7-oh-1,2-benzopyron zur herstellung eines arzneimittels zur behandlung von malignen tumoren beim menschen.
Germain Engineering human tissues for in vivo applications: storage and translational issues for tissue repair and regeneration
DE69516602D1 (de) Verwendung von Bifemelan zur Herstellung eines Arzneimittels zur Behandlung der Hyperkinesie

Legal Events

Date Code Title Description
8363 Opposition against the patent
8331 Complete revocation